DSGN R&D Expense Growth
Design Therapeutics Inc · R&D Expense Growth
DSGN R&D Expense Growth
Latest reported33.32%period ending
DSGN FY R&D Growth (YoY) (0.00% → 33.32%)
Latest values, visible window
High-resolution chart · PNG
DSGN r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 33.3236% | |
| -22.2789% | |
| 17.3822% | |
| 96.1942% | |
| 308.8779% | |
| 266.3845% | |
| 0% |